ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years.

about

The Impact of Emotional Lability Symptoms During Childhood in Adults With ADHD.Stimulant Withdrawal in a Child with Autism Spectrum Disorder and ADHD - A Case Report.

P2860

Q47681601-099CD68A-0186-4735-990B-9543CA99B45D Q55020619-15D43BFB-C879-46E1-89AA-C18FED522347

P2860

ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years.

Item

http://www.wikidata.org/entity/Q50537529

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

ADHD Symptom Rebound and Emoti ...... n Children Aged 6 to 12 Years.

@en

ADHD Symptom Rebound and Emoti ...... n Children Aged 6 to 12 Years.

@nl

type

Item

label

ADHD Symptom Rebound and Emoti ...... n Children Aged 6 to 12 Years.

@en

ADHD Symptom Rebound and Emoti ...... n Children Aged 6 to 12 Years.

@nl

prefLabel

ADHD Symptom Rebound and Emoti ...... n Children Aged 6 to 12 Years.

@en

ADHD Symptom Rebound and Emoti ...... n Children Aged 6 to 12 Years.

@nl

P1476

ADHD Symptom Rebound and Emoti ...... n Children Aged 6 to 12 Years.

@en

P2093

Ann Childress

http://www.w3.org/2001/XMLSchema#string

Ben Adeyi

http://www.w3.org/2001/XMLSchema#string

Brian Scheckner

http://www.w3.org/2001/XMLSchema#string

Bryan Dirks

http://www.w3.org/2001/XMLSchema#string

Frank A López

http://www.w3.org/2001/XMLSchema#string

John Shepski

http://www.w3.org/2001/XMLSchema#string

Robert A Lasser

http://www.w3.org/2001/XMLSchema#string

Thomas Babcock

http://www.w3.org/2001/XMLSchema#string

Valerie Arnold

http://www.w3.org/2001/XMLSchema#string

P2860

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

Rebound effects with long-acting amphetamine or methylphenidate stimulant medication preparations among adolescent male drivers with attention-deficit/hyperactivity disorder.

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

Mania and ADHD: comorbidity or confusion.

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design.

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Can stimulant rebound mimic pediatric bipolar disorder?

Caffeine dependence syndrome. Evidence from case histories and experimental evaluations.

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder.

P304

52-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1087054712474685

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235620369

http://www.w3.org/2001/XMLSchema#string

P698

23407278

http://www.w3.org/2001/XMLSchema#string

ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years.

about

P2860

P2860

ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698